|
1
|
Elpek KG, Rubinstein MP,
Bellemare-Pelletier A, Goldrath AW and Turley SJ: Mature natural
killer cells with phenotypic and functional alterations accumulate
upon sustained stimulation with IL-15/IL-15Ralpha complexes. Proc
Natl Acad Sci USA. 107:21647–21652. 2010. View Article : Google Scholar
|
|
2
|
Stonier SW, Ma LJ, Castillo EF and Schluns
KS: Dendritic cells drive memory CD8 T cell homeostasis via IL-15
transpresentation. Blood. 112:4546–4554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kokaji AI, Hockley DL and Kane KP: IL-15
transpresentation augments CD8+ T cell activation and is
required for optimal recall responses by central memory
CD8+ T cells. J Immunol. 180:4391–401. 2008.PubMed/NCBI
|
|
4
|
Stonier SW and Schluns KS:
Trans-presentation: a novel mechanism regulating IL-15 delivery and
responses. Immunol Lett. 127:85–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dubois S, Mariner J, Waldmann TA and
Tagaya Y: IL-15Rα recycles and presents IL-15 in trans to
neighboring cells. Immunity. 17:537–547. 2002.
|
|
6
|
Mortier E, Quéméner A, Vusio P, Lorenzen
I, Boublik Y, Grötzinger J, Plet A and Jacques Y: Soluble
interleukin-15 receptor α (IL-15Rα)-sushi as a selective and potent
agonist of IL-15 action through IL-15Rβ/γ: hyperagonist
IL-15xIL-15Rα fusion proteins. J Biol Chem. 281:1612–1619.
2006.
|
|
7
|
Dubois S, Patel HJ, Zhang M, Waldmann TA
and Müller JR: Preassociation of IL-15 with IL-15R alpha-IgG1-Fc
enhances its activity on proliferation of NK and
CD8+/CD44high T cells and its antitumor
action. J Immunol. 180:2099–2106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Epardaud M, Elpek KG, Rubinstein MP,
Yonekura AR, Bellemare-Pelletier A, Bronson R, Hamerman JA,
Goldrath AW and Turley SJ: Interleukin-15/interleukin-15R alpha
complexes promote destruction of established tumors by reviving
tumor-resident CD8+ T cells. Cancer Res. 68:2972–2983.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stoklasek TA, Schluns KS and Lefrançois L:
Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity
in vivo. J Immunol. 177:6072–6080. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verdeil G, Marquardt K, Surh CD and
Sherman LA: Adjuvants targeting innate and adaptive immunity
synergize to enhance tumor immunotherapy. Proc Natl Acad Sci USA.
105:16683–16688. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rowley J, Monie A, Hung CF and Wu TC:
Inhibition of tumor growth by NK1.1+ cells and
CD8+ T cells activated by IL-15 through receptor
beta/common gamma signaling in trans. J Immunol. 181:8237–8247.
2008.PubMed/NCBI
|
|
12
|
Jamieson AM, Diefenbach A, McMahon CW,
Xiong N, Carlyle JR and Raulet DH: The role of the NKG2D
immunoreceptor in immune cell activation and natural killing.
Immunity. 17:19–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diefenbach A, Jamieson AM, Liu SD, Shastri
N and Raulet DH: Ligands for the murine NKG2D receptor: expression
by tumor cells and activation of NK cells and macrophages. Nat
Immunol. 1:119–126. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Raulet DH: Roles of the NKG2D
immunoreceptor and its ligands. Nat Rev Immunol. 3:781–790. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
González S, López-Soto A, Suarez-Alvarez
B, López-Vázquez A and López-Larrea C: NKG2D ligands: key targets
of the immune response. Trends Immunol. 29:397–403. 2008.PubMed/NCBI
|
|
16
|
Markiewicz MA, Carayannopoulos LN,
Naidenko OV, Matsui K, Burack WR, Wise EL, Fremont DH, Allen PM,
Yokoyama WM, Colonna M and Shaw AS: Costimulation through NKG2D
enhances murine CD8+ CTL function: similarities and
differences between NKG2D and CD28 costimulation. J Immunol.
175:2825–2833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maasho K, Opoku-Anane J, Marusina AI,
Coligan JE and Borrego F: NKG2D is a costimulatory receptor for
human naive CD8+ T cells. J Immunol. 174:4480–4484.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roberts AI, Lee L, Schwarz E, Groh V,
Spies T, Ebert EC and Jabri B: NKG2D receptors induced by IL-15
costimulate CD28-negative effector CTL in the tissue
microenvironment. J Immunol. 167:5527–5530. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian L, Ji MC, Pan XY, Gong WJ, Tian F and
Duan QF: Construction of a plasmid for co-expression of mouse
membrane-bound form of IL-15 and RAE-1ɛ and its biological
activity. Plasmid. 65:239–245. 2011.PubMed/NCBI
|
|
20
|
Kim GG, Donnenberg VS, Donnenberg AD,
Gooding W and Whiteside TL: A novel multiparametric flow
cytometry-based cytotoxicity assay simultaneously immunophenotypes
effector cells: comparisons to a 4 h 51Cr-release assay. J Immunol
Methods. 325:51–66. 2007. View Article : Google Scholar
|
|
21
|
Cho BK, Rao VP, Ge Q, Eisen HN and Chen J:
Homeostasis-stimulated proliferation drives naive T cells to
differentiate directly into memory T cells. J Exp Med. 192:549–556.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramanathan S, Gagnon J, Dubois S,
Forand-Boulerice M, Richter MV and Ilangumaran S: Cytokine synergy
in antigen-independent activation and priming of naive
CD8+ T lymphocytes. Crit Rev Immunol. 29:219–239. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramanathan S, Gagnon J and Ilangumaran S:
Antigen-nonspecific activation of CD8+ T lymphocytes by
cytokines: relevance to immunity, autoimmunity, and cancer. Arch
Immunol Ther Exp (Warsz). 56:311–323. 2008.PubMed/NCBI
|
|
24
|
Gagnon J, Ramanathan S, Leblanc C,
Cloutier A, McDonald PP and Ilangumaran S: IL-6, in synergy with
IL-7 or IL-15, stimulates TCR-independent proliferation and
functional differentiation of CD8+ T lymphocytes. J
Immunol. 180:7958–7968. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng R, Spolski R, Finkelstein SE, Oh S,
Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN,
Restifo NP, Berzofsky JA and Leonard WJ: Synergy of IL-21 and IL-15
in regulating CD8+ T cell expansion and function. J Exp
Med. 201:139–148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kovanen PE and Leonard WJ: Cytokines and
immunodeficiency diseases: critical roles of the gamma(c)-dependent
cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling
pathways. Immunol Rev. 202:67–83. 2004. View Article : Google Scholar
|
|
27
|
Rubinstein MP, Kovar M, Purton JF, Cho JH,
Boyman O, Surh CD and Sprent J: Converting IL-15 to a superagonist
by binding to soluble IL-15R{alpha}. Proc Natl Acad Sci USA.
103:9166–9171. 2006.PubMed/NCBI
|
|
28
|
Burkett PR, Koka R, Chien M, Chai S, Boone
DL and Ma A: Coordinate expression and trans presentation of
interleukin (IL)-15Rα and IL-15 supports natural killer cell and
memory CD8+ T cell homeostasis. J Exp Med. 200:825–834.
2004.PubMed/NCBI
|
|
29
|
Schluns KS, Klonowski KD and Lefrançois L:
Transregulation of memory CD8 T-cell proliferation by
IL-15Rα+ bone marrow-derived cells. Blood. 103:988–994.
2004.PubMed/NCBI
|
|
30
|
Zaft T, Sapoznikov A, Krauthgamer R,
Littman DR and Jung S: CD11chigh dendritic cell ablation
impairs lymphopenia-driven proliferation of naive and memory
CD8+ T Cells. J Immunol. 175:6428–6435. 2005.
|
|
31
|
Alves NL, Hooibrink B, Arosa FA and van
Lier RA: IL-15 induces antigen-independent expansion and
differentiation of human naive CD8+ T cells in vitro.
Blood. 102:2541–2546. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang DZ, Wu Z and Ciardelli TL: A point
mutation in interleukin-2 that alters ligand internalization. J
Biol Chem. 271:13349–13355. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kobayashi H, Dubois S, Sato N, Sabzevari
H, Sakai Y, Waldmann TA and Tagaya Y: The role of trans-cellular
IL-15-presentation in the activation of NK-mediated killing, which
leads to enhanced tumor immune surveillance. Blood. 105:721–727.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Groh V, Rhinehart R, Randolph-Habecker J,
Topp MS, Riddell SR and Spies T: Costimulation of CD8αβ T cells by
NKG2D via engagement by MIC induced on virus-infected cells. Nat
Immunol. 2:255–260. 2001.
|
|
35
|
Meresse B, Chen Z, Ciszewski C, Tretiakova
M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T,
Ebert EC, Green PH and Jabri B: Coordinated induction by IL15 of a
TCR-independent NKG2D signaling pathway converts CTL into
lymphokine-activated killer cells in celiac disease. Immunity.
21:357–366. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Budagian V, Bulanova E, Paus R and
Bulfone-Paus S: IL-15/IL-15 receptor biology: a guided tour through
an expanding universe. Cytokine Growth Factor Rev. 17:259–280.
2006. View Article : Google Scholar : PubMed/NCBI
|
